Danés, principal investigator of the Cancer and Stem Cell Biology Lab at the Champalimaud Foundation, in Lisbon, has shown ...
T-VEC enables BCC resectability in 50% of cases, showing promise as a neoadjuvant therapy with mild side effects.
PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...
AN EMMERDALE actor today showed off a huge scar on his face, after revealing he had an op to remove deadly skin cancer. The ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
An Emmerdale actor has shared an update after undergoing an operation to have skin cancer removed from his face. Liam Fox, ...
"The new treatment option for basal cell carcinoma can not only simplify surgery, but also help to avoid disfiguring operations and functional limitations," adds first author Julia Ressler ...
It is a useful therapy with several drawbacks that limit its effectiveness, including prolonged light sensitivity, poor ...
A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.
The probability of freedom from recurrence 5 years after surgical excision was higher than with a noninvasive approach in patients with nodular basal cell carcinoma, although the analysis did not show ...
The actor, 54, had a procedure done to remove basal cell carcinoma from his face and is warning his fans to take care and ...
Percentage of biopsies with a diagnosis of cutaneous Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC), or melanoma (including in situ disease) in which the pathologist communicates results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results